Bioinformatically-expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research（2022）
摘要
Leveraging our integrated bioinformatic approach, targeted therapy benefit was observed across diverse MET amplification contexts.
更多查看译文
关键词
tumors,number alterations,analysis optimizes identification,next-generation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要